• DOT1L Inhibition as a Renal Fibrosis Mechanism

  2026-09-04

  The reference study identifies DOT1L-dependent H3K79 methylation as a modifiable regulator of renal fibroblast activation and epithelial–mesenchymal transition in obstructive kidney injury. Its combined animal, cell-based, and genetic evidence supports DOT1L inhibition as a mechanistic research strategy for studying renal fibrosis, while also defining important limits for translation beyond the tested models.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-09-03

  The 2024 Autophagy study identifies a double-positive feedback loop linking AMPK and SQSTM1/p62 during metabolic stress. This circuit coordinates lysosomal signaling, KEAP1 degradation, NRF2 activation, and antioxidant adaptation, providing a mechanistic framework for understanding stress resilience in STK11- and KEAP1-altered lung cancer.

• Nadolol (SQ-11725) Experimental Workflows

  2026-09-03

  Nadolol (SQ-11725) enables controlled perturbation of non-selective beta-adrenergic signaling in cardiovascular cell, tissue, and pharmacokinetic studies. This workflow-focused guide combines receptor-pathway assays with transporter-aware exposure checks, helping researchers distinguish pharmacology from distribution effects.

• Coumestrol: ER Antagonism Meets Ferroptosis

  2026-09-02

  Coumestrol is a phytoestrogen estrogen receptor antagonist that connects nuclear receptor pharmacology with ferroptosis research in rheumatoid arthritis synoviocytes. This article presents a mechanism-centered framework for interpreting concentration, mitochondrial, and PMAIP1-dependent assay data.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-09-02

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, or otherwise difficult DNA templates where standard Taq-based workflows may be inadequate. It is appropriate for blunt-ended products used in cloning and sequencing, but should not be selected when 3′-A overhangs or sticky-end ligation products are required.

• Capsazepine: An Assay Logic for TRPV1 Studies

  2026-09-01

  Capsazepine is a TRPV1 ion channel antagonist that can help separate sensory transduction from broader inflammatory and affective responses. This guide combines channel pharmacology with insights from a recent cannabidiol pain study to improve assay interpretation, controls, and translational restraint.

• Dabigatran Etexilate as an Oral Direct Thrombin Inhibitor

  2026-09-01

  The reference review presents dabigatran etexilate as the first marketed oral direct thrombin inhibitor, emphasizing its rapid, predictable anticoagulant activity and oral alternative to vitamin K antagonists and low-molecular-weight heparins. Its evidence synthesis connects prodrug activation, pharmacokinetics, coagulation assays, clinical efficacy, bleeding risk, and renal function to the practical design of anticoagulation research.

• Amorolfine Hydrochloride and the Integrity Frontier

  2026-08-31

  A systems-level perspective on how Amorolfine Hydrochloride can support fungal cell membrane disruption studies, connect membrane biology with ploidy limits, and strengthen translational antifungal research.

• Carbenoxolone disodium: Lab Workflow Guide

  2026-08-31

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best suited to cell- and tissue-based mechanistic workflows, not in vivo efficacy studies or experiments requiring a highly selective single-target probe.

• Capsaicin Workflows for TRPV1 and KDM1A Studies

  2026-08-30

  Capsaicin is a versatile research tool that connects TRPV1 ion channel activation with reversible KDM1A/LSD1 inhibition. This practical guide helps researchers separate pain and inflammation signaling from epigenetic effects in neuronal, dermatitis, and gastric cancer workflows.

• Hexamethonium Bromide: Reliable Assay Controls

  2026-08-29

  Learn how Hexamethonium Bromide (SKU B1592) can clarify cholinergic and ganglionic contributions in cell-based and cardiovascular experiments without being mistaken for a direct viability reagent. This scenario-driven guide combines practical handling advice with quantitative findings from conscious-mouse hypertension research.

• Veratridine: From Channel Opening to Translation

  2026-08-28

  Veratridine is more than a sodium-channel activator: it is a mechanistic stress test for linking membrane excitability to excitotoxic injury, assay performance, and translational decision-making.

• Capsaicin: TRPV1 and KDM1A Workflows

  2026-08-28

  Capsaicin enables side-by-side investigation of TRPV1 ion channel activation, pain signaling, inflammation, and KDM1A-dependent cancer phenotypes. This workflow-focused guide shows how to separate receptor pharmacology from epigenetic and cytotoxic effects while improving reproducibility in cell, neuron, and disease-model studies.

• RPS6 Signaling as a Translational Readout in PDAC

  2026-08-27

  The LRRC8A–Caveolin-1 axis connects cell-volume regulation with KRAS/EGFR signaling, ribosome biogenesis, and growth in pancreatic ductal adenocarcinoma. This article explains how an Anti-RPS6 antibody can strengthen translational workflows by linking mechanistic biology to reproducible Western blot, immunofluorescence, and immunoprecipitation strategies.

• Ceruletide: Designing Better Pancreatitis Models

  2026-08-27

  Ceruletide, also known as Caerulein, is more than a secretagogue: it is a controllable perturbation for linking pancreatic injury to fibrosis biology. This guide shows how to design mechanistically informative assays around CCK signaling, autophagic flux, and the ORM2–ZG16 pathway.

8059 records 1/538 page Next 12345 下5页 Last page